The Journal of Clinical Endocrinology & Metabolism
Approach to the Patient: Theranostics as precision medicine for neuroendocrine tumors
Abstract Context Theranostics has emerged as a precision medicine paradigm in neuroendocrine tumors (NETs), integrating receptor-based imaging with targeted radionuclide therapy to individualize treatment. This approach is particularly valuable in functional and biologically heterogeneous NETs, where hormonal control and variable clinical behavior dominate therapeutic priorities. Case Description We present a three-case series illustrating the application of theranostics across diverse NET contexts. Case 1 describe …